Insider · CIK 0001493056
Preston Klassen
Files at: ARNA, CNAT, OREXQ. On EDGAR ↗
Reported trades — common stock
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 7, 2019 SForm 4 → | Jan 8, 9:04 pm EST | ARENA PHARMACEUTICALS INCARNA | 19,000 | $42.06 | $799,066 | 0 | −100% | plan? |
| Jan 7, 2019 MForm 4 → | Jan 8, 9:04 pm EST | ARENA PHARMACEUTICALS INCARNA | 19,000 | $15.10 | $286,900 | 3,000 | — | plan? |
| May 30, 2015 AForm 4 → | Feb 4, 2016, 12:06 pm EST | Orexigen Therapeutics, Inc.OREX | 6,030 | $2.69 | $16,221 | 10,160 | — | plan? late |
| May 30, 2014 AForm 4 → | Feb 5, 2015, 5:32 pm EST | Orexigen Therapeutics, Inc.OREX | 2,860 | $5.07 | $14,506 | 4,130 | — | plan? late |
Reported trades — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Company | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 4, 2019 AMForm 4 → | Jan 8, 9:04 pm EST | ARENA PHARMACEUTICALS INCARNA | 106,600 | — | — | 110,350 | — | |
| Jun 21, 2018 AForm 4 → | Jun 25, 4:06 pm EDT | Conatus Pharmaceuticals Inc.CNAT | 20,000 | — | — | 20,000 | — | |
| Jan 19, 2018 AForm 4 → | Jan 22, 5:30 pm EST | ARENA PHARMACEUTICALS INCARNA | 130,000 | — | — | 130,000 | — | |
| Jun 22, 2017 AForm 4 → | Jun 26, 4:16 pm EDT | Conatus Pharmaceuticals Inc.CNAT | 20,000 | — | — | 20,000 | — | |
| Mar 20, 2017 AForm 4 → | Mar 20, 5:54 pm EDT | ARENA PHARMACEUTICALS INCARNA | 1,293,500 | — | — | 1,293,500 | — | |
| Jun 23, 2016 AForm 4 → | Jun 24, 4:21 pm EDT | Conatus Pharmaceuticals Inc.CNAT | 20,000 | — | — | 20,000 | — | |
| Feb 2, 2016 AForm 4 → | Feb 4, 12:06 pm EST | Orexigen Therapeutics, Inc.OREX | 540,000 | — | — | 350,000 | — | |
| Jun 11, 2015 AForm 4 → | Jun 15, 4:08 pm EDT | Conatus Pharmaceuticals Inc.CNAT | 15,000 | — | — | 15,000 | — | |
| Feb 3, 2015 AForm 4 → | Feb 5, 5:32 pm EST | Orexigen Therapeutics, Inc.OREX | 182,650 | — | — | 182,650 | — |